NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)

Clinical trials for NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear

Sign up with your email to follow new studies for NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New drug injected into tumors to wake up immune system against cancer

Disease control Terminated

This early-phase study tested a new experimental drug designed to stimulate the body's immune system to fight cancer. The drug was injected directly into tumors in adults with advanced solid cancers that had stopped responding to standard treatments. Researchers aimed to find a s…

Matched conditions: NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)

Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)

Get alerted when new NEOADJUVANT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear

New drug injected into tumors to wake up immune system against cancer